Prevalence of cardiometabolic co-morbidities in patients with vs persons without chronic hepatitis B: The FitLiver cohort study

doi:10.4254/wjh.v17.i1.97797

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (123)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-3)

Sum=62

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=54

Publishing Process of This Article

Item

Count

Browse

Download

Sum=2

Jan 27, 2025 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Hepatol. Jan 27, 2025; 17(1): 97797
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.97797

Open in New Tab Full Size Figure Download Figure

Figure 1 Flowchart of screening and inclusion of patients with chronic hepatitis B and a comparison group without chronic hepatitis B matched on age, sex, body mass index, and country-of-birth in the FitLiver cohort. HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus.

Citation: Jespersen S, Fritt-Rasmussen A, Madsbad S, Pedersen BK, Krogh-Madsen R, Weis N. Prevalence of cardiometabolic co-morbidities in patients with vs persons without chronic hepatitis B: The FitLiver cohort study. World J Hepatol 2025; 17(1): 97797
URL: https://www.wjgnet.com/1948-5182/full/v17/i1/97797.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i1.97797